Table 2.
Anaemia† (n/N 138/158) | Severe anaemia† (n/N 222/667) | Severe microcytosis† (n/N 125/850) | |||||||
---|---|---|---|---|---|---|---|---|---|
Variable | HR | 95 % CI | P value‡ | HR | 95 % CI | P value‡ | HR | 95 % CI | P value‡ |
Immunological | |||||||||
CD4 T-cell count (per 100 cells) | – | – | – | 0·87 | 0·81, 0·94 | <0·001 | 0·82 | 0·73, 0·91 | <0·001 |
CD8 T-cell count (per 100 cells) | – | – | – | 1·07 | 1·02, 1·11 | <0·01 | 1·08 | 1·02, 1·14 | <0·01 |
Nutritional | |||||||||
Hb (per 10 g/l) | 0·75 | 0·58, 0·96 | 0·02 | – | – | – | 0·77 | 0·67, 0·87 | <0·0001 |
Low vitamin D (<32 ng/ml) | – | – | – | 1·41 | 1·05, 1·89 | 0·02 | 2·38 | 1·58, 3·58 | <0·0001 |
Infections | |||||||||
High ESR (≥81 mm/h) | – | – | – | 1·53 | 1·112, 2·08 | <0·01 | – | – | – |
Hookworm | – | – | – | – | – | – | 1·94 | 1·13, 3·35 | 0·02 |
Malaria | 1·97 | 1·23, 3·15 | <0·01 | – | – | – | – | – | – |
Pathogenic protozoa§ | 1·83 | 1·00, 3·37 | 0·05 | – | – | – | – | – | – |
Syphilis | – | – | – | – | – | – | 2·34 | 1·15, 4·74 | 0·02 |
Additional variables | |||||||||
Second pregnancy‖ | 0·49 | 0·29, 0·83 | <0·01 | 0·41 | 0·30, 0·58 | <0·0001 | 0·47 | 0·31, 0·70 | <0·001 |
HR, hazard ratio; ESR, erythrocyte sedimentation rate.
All multivariate analyses were adjusted for multivitamin regimen and adherence to prenatal Fe supplementation.
Anaemia: Hb <110 g/l, severe anaemia: Hb <85 g/l, severe microcytosis: hypochromasia ≥2+ and microcytic cells on peripheral smear.
P values were obtained from Cox proportional hazards analyses; women who had the endpoint of interest at baseline were excluded, to examine time to first occurrence of outcome during follow-up.
Giardia lamblia, Entamoeba histolytica or Cryptosporidium parvum.
Second pregnancy after enrolment into the trial.